Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1;17(1):e2025054.
doi: 10.4084/MJHID.2025.054. eCollection 2025.

A case of Severe Gastrointestinal Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation: Can We Improve the Evaluation of the "Gut Fitness"?

Gabriele Magliano  1 , Enrico Morello  1 , Mirko Farina  1 , Vera Radici  1 , Marco Galli  1 , Giulia Brambilla  1 , Michele Malagola  1 , Domenico Russo  1 , Daniele Avenoso  1
Affiliations

A case of Severe Gastrointestinal Toxicity after Allogeneic Hematopoietic Stem Cell Transplantation: Can We Improve the Evaluation of the "Gut Fitness"?

Gabriele Magliano et al. Mediterr J Hematol Infect Dis. .
No abstract available

Keywords: Allogeneic hematopoietic stem cell transplantation; Gastrointestinal mucositis; Invasive fungal infection; Microbiome and dysbiosis; Transplant-related mortality.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no conflict of Interest.

Figures

Figure 1
Figure 1
Summary timeline of the episode of care. Key clinical events and administered therapies are listed in boxes along the timeline. ATG: anti-thymocyte globulin; GI: gastrointestinal; MTX: methotrexate; Pip/Taz: piperacillin/tazobactam.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Jansen SA, Nieuwenhuis EES, Hanash AM, Lindemans CA. Challenges and opportunities targeting mechanisms of epithelial injury and recovery in acute intestinal graft-versus-host disease. Mucosal Immunol. 2022 Apr;15(4):605–619. doi: 10.1038/s41385-022-00527-6. - DOI - PMC - PubMed
    1. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005 Oct 15;106(8):2912–9. doi: 10.1182/blood-2005-05-2004. - DOI - PMC - PubMed
    1. Malagola M, Polverelli N, Martino M, et al. Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study. Transplant Direct. 2023 Feb 22;9(3):e1451. doi: 10.1097/TXD.0000000000001451. - DOI - PMC - PubMed
    1. Wardill HR, Sonis ST, Blijlevens NMA, et al. Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action. Support Care Cancer. 2020 Nov;28(11):5059–5073. doi: 10.1007/s00520-020-05579-7. - DOI - PubMed
    1. Kuiken NSS, Rings EHHM, Blijlevens NMA, Tissing WJE. Biomarkers and non-invasive tests for gastrointestinal mucositis. Support Care Cancer. 2017 Sep;25(9):2933–2941. doi: 10.1007/s00520-017-3752-2. - DOI - PMC - PubMed